CONCORDE INTERNATION-CLASS A (CIGL) Fundamental Analysis & Valuation

NASDAQ:CIGL • VGG2452S1002

Current stock price

1.92 USD
-0.16 (-7.69%)
Last:

This CIGL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CIGL Profitability Analysis

1.1 Basic Checks

  • CIGL had a negative operating cash flow in the past year.
CIGL Yearly Net Income VS EBIT VS OCF VS FCFCIGL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

  • The Return On Assets of CIGL (-814.13%) is worse than 95.12% of its industry peers.
  • CIGL has a Return On Equity of -3966.49%. This is amonst the worse of the industry: CIGL underperforms 89.02% of its industry peers.
Industry RankSector Rank
ROA -814.13%
ROE -3966.49%
ROIC N/A
ROA(3y)-271.31%
ROA(5y)N/A
ROE(3y)-1327%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CIGL Yearly ROA, ROE, ROICCIGL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

  • The Gross Margin of CIGL (34.46%) is comparable to the rest of the industry.
  • CIGL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CIGL Yearly Profit, Operating, Gross MarginsCIGL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CIGL Health Analysis

2.1 Basic Checks

  • CIGL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CIGL has about the same amout of shares outstanding than it did 1 year ago.
  • CIGL has a worse debt/assets ratio than last year.
CIGL Yearly Shares OutstandingCIGL Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M 20M
CIGL Yearly Total Debt VS Total AssetsCIGL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • Based on the Altman-Z score of -21.35, we must say that CIGL is in the distress zone and has some risk of bankruptcy.
  • CIGL has a Altman-Z score of -21.35. This is amonst the worse of the industry: CIGL underperforms 92.68% of its industry peers.
  • CIGL has a Debt/Equity ratio of 1.46. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of CIGL (1.46) is worse than 73.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.46
Debt/FCF N/A
Altman-Z -21.35
ROIC/WACCN/A
WACC8.61%
CIGL Yearly LT Debt VS Equity VS FCFCIGL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 1M -1M 2M 3M

2.3 Liquidity

  • CIGL has a Current Ratio of 1.17. This is a normal value and indicates that CIGL is financially healthy and should not expect problems in meeting its short term obligations.
  • CIGL has a worse Current ratio (1.17) than 62.20% of its industry peers.
  • CIGL has a Quick Ratio of 1.17. This is a normal value and indicates that CIGL is financially healthy and should not expect problems in meeting its short term obligations.
  • CIGL has a Quick ratio of 1.17. This is comparable to the rest of the industry: CIGL outperforms 45.12% of its industry peers.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.17
CIGL Yearly Current Assets VS Current LiabilitesCIGL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. CIGL Growth Analysis

3.1 Past

  • The Revenue has decreased by -1.55% in the past year.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-1.55%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.55%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CIGL Yearly Revenue VS EstimatesCIGL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

Find the best growth stocksShow best growing peers

0

4. CIGL Valuation Analysis

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CIGL Price Earnings VS Forward Price EarningsCIGL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CIGL Per share dataCIGL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CIGL Dividend Analysis

5.1 Amount

  • No dividends for CIGL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CIGL Fundamentals: All Metrics, Ratios and Statistics

CONCORDE INTERNATION-CLASS A

NASDAQ:CIGL (3/20/2026, 8:00:00 PM)

1.92

-0.16 (-7.69%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners1.88%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap51.82M
Revenue(TTM)10.49M
Net Income(TTM)-83.64M
AnalystsN/A
Price TargetN/A
Short Float %0.48%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.94
P/FCF N/A
P/OCF N/A
P/B 24.58
P/tB 24.68
EV/EBITDA N/A
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.39
BVpS0.08
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -814.13%
ROE -3966.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.46%
FCFM N/A
ROA(3y)-271.31%
ROA(5y)N/A
ROE(3y)-1327%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 1.46
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 376.43%
Cap/Sales 10.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 1.17
Altman-Z -21.35
F-Score2
WACC8.61%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.55%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6824.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-526.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-171.34%
OCF growth 3YN/A
OCF growth 5YN/A

CONCORDE INTERNATION-CLASS A / CIGL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CONCORDE INTERNATION-CLASS A?

ChartMill assigns a fundamental rating of 0 / 10 to CIGL.


What is the valuation status for CIGL stock?

ChartMill assigns a valuation rating of 0 / 10 to CONCORDE INTERNATION-CLASS A (CIGL). This can be considered as Overvalued.


Can you provide the profitability details for CONCORDE INTERNATION-CLASS A?

CONCORDE INTERNATION-CLASS A (CIGL) has a profitability rating of 0 / 10.